...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019

iconoclast, that is precisely the thought jumped into my head when I read that statement.

Exciting science but not quite there yet so lots of trial work to come. We'll see. I really hope the results are significant enough for the FDA to give clinical consideration as is to this target or to a more refined target.

Toinv

Share
New Message
Please login to post a reply